Key result
IFN-I signaling in human THP1 cells absolutely depends on IFNAR2, while a CRISPR/Cas9-induced 7-bp deletion mutant remains responsive to IFNβ stimulation due to exon skipping.
Why the study?
The role of IFNAR2 in type I interferon signaling remained an open question after a previous report showed that IFNβ was functional without IFNAR2 in mice.
The study clarifies the absolute requirement of IFNAR2 for human IFN-I signaling and highlights the risk of residual protein expression due to exon skipping when using CRISPR/Cas9.
Alerts to exon skipping in CRISPR IFNAR2 models; leaves open need for primary-cell validation in IFN-I studies.
Type I interferons (IFN-Is) play central roles in regulating immune responses. The role of IFNAR2 in IFN-I signaling is an open question since a previous report showed that IFNβ was still functional in the absence of IFNAR2 in mice. In this study, we report that IFN-I signaling in human monocyte-derived THP1 cells absolutely depends on IFNAR2, as determined by using a knockout mutant made by CRISPR/Cas9. Additionally, we demonstrated that a 7-bp deletion mutant (Δ7) of IFNAR2 remains responsive to IFNβ stimulation and upregulates a subset of interferon-stimulated genes (s-ISGs). The s-ISGs largely overlap with tonic ISGs, which depend on the basal expression level of IFN-I. We also showed that IFN signaling in Δ7 still depends on IFNAR2. Then, we found that the 7-bp deletion in the genome results in the loss of the entire third exon (42 bp) from the mRNA and in the expression of a functionally impaired IFNAR2. These findings clarified the requirement of IFNAR2 for human IFN-I signaling and highlighted that caution should be used with CRISPR/Cas9 technology to prevent misleading interpretations caused by residual protein expression due to exon skipping or other mechanisms.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question. CRISPR/Cas9-induced IFNAR2 mutation was evaluated on IFN-I signaling dependence on IFNAR2. IFN-I signaling in human THP1 cells absolutely depends on IFNAR2, while a CRISPR/Cas9-induced 7-bp deletion mutant remains responsive to IFNβ stimulation due to exon skipping.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: